Exercise triggers hepatic release of GPLD1, an enzyme that cleaves endothelial TNAP to rejuvenate cerebrovascular signaling and enhance cognition while reducing Alzheimer's pathology. This discovery establishes a direct molecular pathway by which liver-derived signals mediate exercise's neuroprotective effects. The finding fundamentally shifts our understanding of how physical activity combats neurodegeneration—not just through direct brain effects, but via systemic metabolic communication between organs. This liver-brain enzymatic axis suggests that exercise benefits may persist through circulating hepatokines even after workout cessation. The research validates exercise as medicine for cognitive health, providing mechanistic support for physical activity prescriptions in aging populations. However, the work appears to be commentary on another study rather than original research, limiting immediate clinical applications. The identification of GPLD1 as a key exercise mediator opens therapeutic possibilities—potentially allowing pharmacological mimicking of exercise benefits for those unable to maintain physical activity. This organ crosstalk paradigm suggests that metabolic health optimization through exercise creates brain-protective cascades throughout the body.